Tamoxifen Citrate
16 NDCs across 5 manufacturers|15 Generic,1 Brand
Tamoxifen Citrate is used to treat breast neoplasms, gynecomastia, pancreatic neoplasms and precocious puberty, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Feb 20, 2003. FDA's Orange Book lists 10 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $11 million on Tamoxifen Citrate across 384,000 claims for 100,000 beneficiaries.
Tamoxifen Citrate is available as 16 NDCs from 5 manufacturers (15 generic, 1 brand), with NADAC prices from $0.13 to $0.28 per EA — the most expensive product costs about 2.3× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
16
15G / 1B
Manufacturers
5
competing in market
Price Spread
$0.13 – $0.28
per EA, 15 of 16 NDCs
7d Activity
avg -3.9% WoW · of 16 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Actavis Pharma, Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Estrogen Agonist/Antagonist class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
5 manufacturers producing TAMOXIFEN CITRATE(1 pricing outlier)
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
SOLTAMOX 20 MG/10 ML SOLN | $4.4009 per ML | — |
TAMOXIFEN 20 MG TABLET | $0.2848 per EA | — |
TAMOXIFEN 20 MG TABLET | $0.2848 per EA | — |
TAMOXIFEN 20 MG TABLET | $0.2768 per EA | -2.27% |
TAMOXIFEN 20 MG TABLET | $0.2768 per EA | -2.27% |
TAMOXIFEN 20 MG TABLET | $0.2768 per EA | -2.27% |
TAMOXIFEN 20 MG TABLET | $0.2768 per EA | -2.27% |
TAMOXIFEN 20 MG TABLET | $0.2768 per EA | -2.27% |
TAMOXIFEN 20 MG TABLET | $0.2768 per EA | -2.27% |
TAMOXIFEN 20 MG TABLET | $0.2768 per EA | -2.27% |
TAMOXIFEN 10 MG TABLET | $0.1255 per EA | -5.71% |
TAMOXIFEN 10 MG TABLET | $0.1255 per EA | -5.71% |
TAMOXIFEN 10 MG TABLET | $0.1255 per EA | -5.71% |
TAMOXIFEN 10 MG TABLET | $0.1255 per EA | -5.71% |
TAMOXIFEN 10 MG TABLET | $0.1255 per EA | -5.71% |
TAMOXIFEN 10 MG TABLET | $0.1255 per EA | -5.71% |
Frequently Asked Questions
What is Tamoxifen Citrate used to treat?
Tamoxifen Citrate is used to treat breast neoplasms, gynecomastia, pancreatic neoplasms and precocious puberty, per the National Library of Medicine's MED-RT classification.
When did Tamoxifen Citrate become available as a generic?
FDA approved the first generic Tamoxifen Citrate (ANDA) on Feb 20, 2003. The Orange Book currently lists 10 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Tamoxifen Citrate?
In 2024, Medicare Part D spent $11 million on Tamoxifen Citrate across 384,000 claims for 100,000 beneficiaries.
How many Tamoxifen Citrate products are on the market?
The Tamoxifen Citrate drug market contains 16 NDCs from 5 manufacturers — 15 generic and 1 brand product.
What is the price range for Tamoxifen Citrate?
NADAC reference prices for Tamoxifen Citrate range from $0.1255 to $0.2848 per EA — the most expensive product costs about 2.3× the cheapest. 1 additional product is priced per a different unit (e.g. liquids per ML) and isn't directly comparable.
Which manufacturers make Tamoxifen Citrate?
5 manufacturers list Tamoxifen Citrate in NADAC. Ranked by number of NDCs, the largest are Actavis Pharma, Inc. (4), Dr. Reddy's Laboratories Inc. (4), Mayne Pharma (3), Aurobindo Pharma Limited (3), Mylan Pharmaceuticals Inc. (2).
How has the price of Tamoxifen Citrate changed recently?
Over the past 7 days, 0 Tamoxifen Citrate NDCs rose and 13 fell, with a market-wide average change of -3.9%.